Related Experiment Video

Updated: Aug 30, 2026

Bacterial Expression and Purification of Human Matrix Metalloproteinase-3 using Affinity Chromatography
07:32

Bacterial Expression and Purification of Human Matrix Metalloproteinase-3 using Affinity Chromatography

Published on: March 30, 2022

Matrix metalloproteinase inhibitors

P D Brown1

  • 1Department of Clinical Research, British Biotech Pharmaceuticals Ltd, Oxford OX4 5LY, UK.

Angiogenesis
|October 1, 2003
PubMed

Insights

Matrix metalloproteinases (MMPs) are enzymes involved in tissue remodeling and disease pathogenesis. Synthetic MMP inhibitors show promise in preclinical models and are advancing to human clinical trials for various conditions.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Pharmacology

Background:

  • Matrix metalloproteinases (MMPs) are enzymes degrading extracellular matrix proteins.
  • MMPs play roles in normal tissue remodeling and disease pathogenesis, including cancer, rheumatoid arthritis, and multiple sclerosis.
  • Elevated MMP activity in malignancies correlates with poor prognosis, facilitating tumor invasion, metastasis, and angiogenesis.

Purpose of the Study:

  • To develop low molecular weight synthetic inhibitors targeting MMPs.
  • To evaluate the efficacy of these inhibitors in preclinical disease models.
  • To advance promising MMP inhibitors into clinical trials.

Main Methods:

  • Structure-based drug design was employed to create synthetic MMP inhibitors.
  • Inhibitor efficacy was assessed in relevant animal models of disease.
  • Several compounds (CGS 27023A, AG3340, Ro 32-3555, marimastat) progressed to clinical evaluation.

Main Results:

  • Low molecular weight synthetic MMP inhibitors were successfully developed.
  • These inhibitors demonstrated effectiveness in animal models of various diseases.
  • Multiple MMP inhibitors have entered human clinical trials.

Conclusions:

  • Synthetic MMP inhibitors represent a promising therapeutic strategy.
  • Structure-based design is effective for developing potent MMP inhibitors.
  • Clinical trials are underway to assess the therapeutic potential of these inhibitors in humans.

More Related Videos

Detection of Functional Matrix Metalloproteinases by Zymography09:30

Detection of Functional Matrix Metalloproteinases by Zymography

Published on: November 8, 2010

Related Concept Videos

Role of Matrix Metalloproteases in Degradation of ECM01:23

Role of Matrix Metalloproteases in Degradation of ECM

Matrix metalloproteases (MMPs) are enzymes involved in the hydrolysis of proteins and glycoproteins of the extracellular matrix. MMPs are essential for the migration and proliferation of cells through the dense matrix network, throughout embryonic development, and throughout morphogenesis. The first MMP activity discovered was a collagenase in a tadpole's tail undergoing metamorphosis. The active collagen deposition and modifications lead to the morphogenesis of tadpoles into the adult body.
A...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA ends...
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...